|
1) Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol. 2005; 45: 954-9
|
|
|
|
2) Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol. 2005; 45: 947-53
|
|
|
|
|
|
3) McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004; 364: 1519-21
|
|
|
|
|
|
4) Pfisterer M, Brunner-La Rocca HP, et al; BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006; 48: 2584-91
|
|
|
|
|
|
5) Bavry AA, Kumbhani DJ, Helton TJ, et al. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 2006; 119: 1056-61
|
|
|
|
|
|
6) Luscher TF, Steffel J, Eberli FR et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007; 115: 1051-8
|
|
|
|
|
|
7) Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005; 112: 270-8
|
|
|
|
|
|
8) Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007; 115: 2435-41
|
|
|
|
|
|
9) Virmani R, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious？ Circulation. 2004; 109: 701-5
|
|
|
|
|
|
10) Carter AJ, et al. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res. 2004; 63: 617-24
|
|
|
|
|
|
11) Sousa JE, Costa MA, Farb A. Images in cardiovascular medicine. Vascular healing 4 years after the implantation of sirolimus-eluting stent in humans: a histopathological examination. Circulation. 2004; 110: e5-6
|
|
|
|
|
|
12) Kotani J, Awata M, Nanto S, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol. 2006; 47: 2108-11
|
|
|
|
|
|
13) Oyabu J, Ueda Y, Ogasawara N, et al. Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent. Am Heart J. 2006; 152: 1168-74
|
|
|
|
|
|
14) 高山忠輝, 安藤英之, 遠藤正賢, 他. DES時代のAMI治療・プレホスピタルケアからCCU管理まで その現状と問題点 急性心筋梗塞に対するDES留置の可否 DES留置後の内視鏡所見からの検討. ICUとCCU. 2007; 31: 1006-9
|
|
|
|
|